We are live on ! Find out more
Aster Capital Management

Aster Capital Management Portfolio holdings

AUM $275M Turnover 72.56%
1-Year Est. Return 18.46%
This Fund
S&P 500
This Quarter Est. Return
-1.47%
1 Year Est. Return
+18.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
-$195M
Cap. Flow
-$180M
Cap. Flow %
-65.37%
Top 10 Hldgs %
10.94%
Holding
1,392
New
584
Increased
169
Reduced
213
Closed
426
Avg Time Held
0.2 years
Top 10 Avg Time Held
0 years
Top 20 Avg Time Held
0 years

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.57M
2
OVV icon
Ovintiv
OVV
+$3.99M
3
KIM icon
Kimco Realty
KIM
+$3.52M
4
ALAB icon
Astera Labs
ALAB
+$3.33M
5
HUT icon
Hut 8
HUT
+$2.16M

Top Sells

Rank Stock Value
1
IYR icon
iShares US Real Estate ETF
IYR
+$11.3M
2
AAPL icon
Apple
AAPL
+$7.75M
3
MSFT icon
Microsoft
MSFT
+$6.82M
4
HON icon
Honeywell
HON
+$6.34M
5
KO icon
Coca-Cola
KO
+$5.38M

Sector Composition

Rank Sector Weight
1 Financials 16.08%
2 Technology 15.72%
3 Industrials 13.9%
4 Healthcare 13.43%
5 Consumer Discretionary 10.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ALG icon
826
Alamo Group
ALG
$1.58B
$5.88K ﹤0.01%
+38
New +$6.26K
2026 Q3
0 quarters
RDN icon
827
Radian Group
RDN
$4.61B
$5.78K ﹤0.01%
+189
New +$6.95K
2026 Q3
0 quarters
TYRA icon
828
Tyra Biosciences
TYRA
$1.36B
$5.77K ﹤0.01%
+264
New +$7.26K
2026 Q3
0 quarters
OLMA icon
829
Olema Oncology
OLMA
$626M
$5.58K ﹤0.01%
+646
New +$7.04K
2026 Q3
0 quarters
ITRI icon
830
Itron
ITRI
$4.28B
$5.53K ﹤0.01%
+64
New +$5.99K
2026 Q3
0 quarters
RHLD icon
831
Resolute Holdings Management
RHLD
$1.11B
$5.44K ﹤0.01%
+46
New +$6.05K
2026 Q3
0 quarters
XNCR icon
832
Xencor
XNCR
$2.55B
$5.44K ﹤0.01%
+218
New +$4.85K
2026 Q3
0 quarters
CRVS icon
833
Corvus Pharmaceuticals
CRVS
$844M
$5.3K ﹤0.01%
+460
New +$6.41K
2026 Q3
0 quarters
AMLX icon
834
Amylyx Pharmaceuticals
AMLX
$3.37B
$5.27K ﹤0.01%
181
-212
-54% -$5.62K
2026 Q2
1 quarter
CELC icon
835
Celcuity
CELC
$2.76B
$5.25K ﹤0.01%
+66
New +$6.01K
2026 Q3
0 quarters
AGIO icon
836
Agios Pharmaceuticals
AGIO
$1.72B
$5.19K ﹤0.01%
+156
New +$5.46K
2026 Q3
0 quarters
CXT icon
837
Crane NXT
CXT
$3.12B
$5.13K ﹤0.01%
+109
New +$5.49K
2026 Q3
0 quarters
REAL icon
838
RealReal
REAL
$1.48B
$5.11K ﹤0.01%
+578
New +$6.24K
2026 Q3
0 quarters
ARDT icon
839
Ardent Health
ARDT
$2.04B
$5.08K ﹤0.01%
+491
New +$5.27K
2026 Q3
0 quarters
AEBI icon
840
Aebi Schmidt Holding
AEBI
$735M
$4.93K ﹤0.01%
+466
New +$5.76K
2026 Q3
0 quarters
GERN icon
841
Geron
GERN
$588M
$4.88K ﹤0.01%
+3,968
New +$5.68K
2026 Q3
0 quarters
IIPR icon
842
Innovative Industrial Properties
IIPR
$1.35B
$4.85K ﹤0.01%
+92
New +$5.4K
2026 Q3
0 quarters
ANAB icon
843
AnaptysBio
ANAB
$1.41B
$4.82K ﹤0.01%
+96
New +$5.43K
2026 Q3
0 quarters
PHIN icon
844
Phinia
PHIN
$2.69B
$4.81K ﹤0.01%
+81
New +$5.81K
2026 Q3
0 quarters
CHCO icon
845
City Holding
CHCO
$1.94B
$4.73K ﹤0.01%
+34
New +$4.82K
2026 Q3
0 quarters
IBCP icon
846
Independent Bank Corp
IBCP
$774M
$4.72K ﹤0.01%
+134
New +$4.95K
2026 Q3
0 quarters
USPH icon
847
US Physical Therapy
USPH
$1.41B
$4.72K ﹤0.01%
+55
New +$4.3K
2026 Q3
0 quarters
PFBC icon
848
Preferred Bank
PFBC
$1.18B
$4.71K ﹤0.01%
+45
New +$4.74K
2026 Q3
0 quarters
TS icon
849
Tenaris
TS
$29B
$4.69K ﹤0.01%
+85
New +$4.71K
2026 Q3
0 quarters
HTB icon
850
HomeTrust Bancshares
HTB
$720M
$4.67K ﹤0.01%
102
+36
+55% +$1.74K
2026 Q2
1 quarter

Similar funds

Aster Capital Management's Q3 2026 Portfolio in Review

As of Q3 2026, Aster Capital Management held 1,392 positions worth $275M, down 41% from $470M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Aster Capital Management withdrew a net $180M in Q3 2026, closing 426 positions and reducing 213 holdings. Its most notable exit was iShares US Real Estate ETF, an estimated $11.3M position sold in full.

By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Aster Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.43M.

  • Aster Capital Management's largest Q3 2026 buy was Alnylam Pharmaceuticals: 17,949 shares worth $4.43M.
  • Aster Capital Management added most to Simon Property Group in Q3 2026, an estimated $1.93M increase.
  • Aster Capital Management's biggest Q3 2026 reduction was Meta Platforms (Facebook), cutting an estimated $4.29M.
  • Aster Capital Management fully exited iShares US Real Estate ETF in Q3 2026, selling an estimated $11.3M.
  • Aster Capital Management's ten largest holdings make up 11% of its $275M portfolio in Q3 2026.
  • Aster Capital Management opened 584 new positions and closed 426 in Q3 2026.
  • Aster Capital Management's portfolio value fell 41% quarter-over-quarter to $275M.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.